In this podcast, Craig W. Hendrix, MD, discusses pre-exposure prophylaxis (PrEP) medications that are being reviewed by the US Food and Drug Administration, as well as those in clinical trials—a topic he also spoke about at IDWeek 2019. More at: www.consultant360.com/infectious-diseases.

In this podcast, Craig W. Hendrix, MD, discusses pre-exposure prophylaxis (PrEP) medications that are being reviewed by the US Food and Drug Administration, as well as those in clinical trials—a topic he also spoke about at IDWeek 2019. More at: www.consultant360.com/infectious-diseases.

In this podcast, Craig W. Hendrix, MD, discusses pre-exposure prophylaxis (PrEP) medications that are being reviewed by the US Food and Drug Administration, as well as those in clinical trials—a topic he also&nbsp;spoke about at IDWeek 2019. More at: www.consultant360.com/infectious-diseases.

Craig Hendrix, MD, on PrEP Medications to Watch Out For

Podcasts360, powered by Consultant360, features short interviews with medical professionals about current research, news, and general information for health care providers in 35+ specialties.

Share Craig Hendrix, MD, on PrEP Medications to Watch Out For

Sign up to save your podcasts

Craig Hendrix, MD, on PrEP Medications to Watch Out For

Craig Hendrix, MD, on PrEP Medications to Watch Out For

More shows like Podcasts360

The Curbsiders Internal Medicine Podcast